{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:18:35Z","timestamp":1792880315447,"version":"4.5.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1007\/s11914-006-0006-5","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T16:56:31Z","timestamp":1180716991000},"page":"76-79","source":"Crossref","is-referenced-by-count":7,"title":["Bone quality: A perspective from the food and drug administration"],"prefix":"10.1007","volume":"4","author":[{"given":"Theresa","family":"Kehoe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"6_CR1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","volume":"285","author":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy","year":"2001","unstructured":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy: Osteoporosis prevention, diagnosis, and therapy [review]. JAMA 2001, 285:785\u2013795.","journal-title":"JAMA"},{"key":"6_CR2","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1001\/jama.284.23.3043","volume":"284","author":"World Medical Association Declaration of Helsinki","year":"2000","unstructured":"World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 2000, 284:3043\u20133045.","journal-title":"JAMA"},{"key":"6_CR3","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1359\/jbmr.2003.18.6.1160","volume":"18","author":"A Capron","year":"2003","unstructured":"Capron A, Donaldson S, Raisz LG, Swift S: Osteoporosis panel summary. J Bone Miner Res 2003, 18:1160\u20131162. This article summarizes a collection of articles in the Journal of Bone and Mineral Research that encapsulates the presentations and discussions from the June, 2002, National Institutes of Health conference on study design and ethical considerations for osteoporosis drug development trials.","journal-title":"J Bone Miner Res"},{"key":"6_CR4","unstructured":"US Food and Drug Administration, Center for Drug Evaluation and Research: Endocrinologic and Metabolic Drugs Advisory Committee meeting documents. Silver Spring, MD, September 25, 2002. http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/cder02.htm#EndocrinologicMetabolicDrugs. Accessed January 21, 2006."},{"key":"6_CR5","first-page":"3","volume-title":"Clinical Measurement in Drug Evaluation","author":"RJ Temple","year":"1995","unstructured":"Temple RJ: A regulatory authority\u2019s opinion about surrogate endpoints. In Clinical Measurement in Drug Evaluation. Edited by Nimmo WS and Tucker GT. New York: John Wiley & Sons; 1995:3\u201322. This chapter provides an overview of surrogate endpoints in the drug approval process. It focuses mainly on endpoints related to cardiovascular outcomes."},{"key":"6_CR6","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1359\/jbmr.2003.18.6.1125","volume":"18","author":"EG Colman","year":"2003","unstructured":"Colman EG: The Food And Drug Administration\u2019s osteoporosis guidance document: past, present, and future. J Bone Miner Res 2003, 18:1125\u20131128. This article provides a comprehensive history of the FDA\u2019s guidelines for preclinical and clinical evaluation of agents used in the prevention or treatment of osteoporosis.","journal-title":"J Bone Miner Res"},{"key":"6_CR7","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1056\/NEJM199003223221203","volume":"322","author":"BL Riggs","year":"1990","unstructured":"Riggs BL, Hodgon SF, O\u2019Fallon WM, et al.: Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990, 322:802\u2013809.","journal-title":"N Engl J Med"},{"key":"6_CR8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0002-9343(93)90350-X","volume":"95","author":"ST Harris","year":"1993","unstructured":"Harris ST, Watts NB, Jackson RD, et al.: Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy. Am J Med 1993, 95:557\u2013567.","journal-title":"Am J Med"},{"key":"6_CR9","unstructured":"US Food and Drug Administration, Center for Drug Evaluation and Research, Guidelines for Preclinical and Clinical Evaluation of Agents Used in the Prevention or Treatment of Postmenopausal Osteoporosis. http:\/\/www. fda.gov\/Cder\/guidance\/osteo.pdf."}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-006-0006-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-006-0006-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-006-0006-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:31:52Z","timestamp":1559435512000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-006-0006-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["6"],"URL":"https:\/\/doi.org\/10.1007\/s11914-006-0006-5","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}